Related Experiment Video
Updated: May 16, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Silver nitrate in interventional pulmonology: treating a case of persistent bronchopleural fistula
Dinesh Mehta1, Chavi Mehta, Sanchit Wadhwa
1Department of Pulmonary Medicine, Mehta Clinic and Nursing Home, India. drdineshmehta@gmail.com
Abstract:
Bronchopleural fistula (BPF) is a communication between the pleural space and the bronchial tree. A BPF occurs when an injured bronchus fails to heal; the condition is associated with high morbidity. The treatment of persistent BPF includes various surgical procedures. Conventional surgical strategies such as thoracoplasty or chest wall fenestration carry significant mortality and long-term morbidity with pain and deformity. Reducing the morbidity of therapy with a minimal access approach is, therefore, appealing. In recent years, bronchoscopic management of BPF in terms of recognizing the site of fistula and blocking the leaking segment with many agents available has attained success and has been considered an established mode of management. The use of silver nitrate in treatment of BPF has staged a comeback, offering very good results.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due to...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
